Femasys Inc
FEMY0.812USD
-0.008-0.95%
取引時間 （ET）15分遅れの株価
21.99M時価総額
損失額直近12ヶ月PER
詳細情報 Femasys Inc 企業名
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
企業情報
企業コードFEMY
会社名Femasys Inc
上場日Jun 18, 2021
最高経営責任者「CEO」Ms. Kathy Lee-Sepsick
従業員数69
証券種類Ordinary Share
決算期末Jun 18
本社所在地3950 Johns Creek Court
都市SUWANEE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号30024
電話番号17705003910
ウェブサイトhttps://www.femasys.com/
企業コードFEMY
上場日Jun 18, 2021
最高経営責任者「CEO」Ms. Kathy Lee-Sepsick
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
384.31K
+9.80%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Dr. James Liu, M.D.
Dr. James Liu, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Independent Director
Independent Director
--
--
Mr. Daniel Currie
Mr. Daniel Currie
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Edward Uzialko, Jr.
Mr. Edward Uzialko, Jr.
Independent Director
Independent Director
--
--
Ms. Christine Thomas
Ms. Christine Thomas
Chief Regulatory and Clinical Officer
Chief Regulatory and Clinical Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
384.31K
+9.80%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Dr. James Liu, M.D.
Dr. James Liu, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
収益内訳
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
データなし
地域別USD
会社名
収益
比率
United States
341.26K
0.00%
事業別
地域別
データなし
株主
更新時刻: Fri, Jul 18
更新時刻: Fri, Jul 18
株主統計
種類
株主統計
株主統計
比率
Chernett (Jorey)
4.99%
Dauntless Investment Group, LLC
4.84%
Uzialko (Edward R Jr.)
3.74%
The Vanguard Group, Inc.
2.54%
CM Management, LLC
1.31%
Other
82.58%
株主統計
株主統計
比率
Chernett (Jorey)
4.99%
Dauntless Investment Group, LLC
4.84%
Uzialko (Edward R Jr.)
3.74%
The Vanguard Group, Inc.
2.54%
CM Management, LLC
1.31%
Other
82.58%
種類
株主統計
比率
Individual Investor
10.52%
Investment Advisor
10.24%
Investment Advisor/Hedge Fund
1.26%
Hedge Fund
0.23%
Venture Capital
0.10%
Research Firm
0.09%
Bank and Trust
0.05%
Other
77.52%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
70
7.31M
22.48%
+821.23K
2025Q1
67
7.22M
24.70%
+706.34K
2024Q4
60
4.03M
17.61%
-312.38K
2024Q3
58
3.32M
14.71%
-994.98K
2024Q2
60
3.27M
14.50%
-951.60K
2024Q1
59
3.16M
17.88%
-1.13M
2023Q4
59
3.12M
17.80%
-765.84K
2023Q3
57
3.89M
25.74%
+6.18K
2023Q2
54
3.49M
25.26%
-520.59K
2023Q1
51
3.40M
28.73%
-4.68M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Chernett (Jorey)
1.62M
4.99%
+1.62M
--
Feb 19, 2025
Dauntless Investment Group, LLC
1.58M
4.84%
+145.30K
+10.16%
Mar 31, 2025
Uzialko (Edward R Jr.)
1.22M
3.74%
--
--
Apr 08, 2025
The Vanguard Group, Inc.
825.67K
2.54%
--
--
Mar 31, 2025
CM Management, LLC
425.00K
1.31%
--
--
Mar 31, 2025
Lee-Sepsick (Kathy)
384.31K
1.18%
+34.31K
+9.80%
Jun 02, 2025
Clear Creek Financial Management, LLC
270.37K
0.83%
+14.00K
+5.46%
Mar 31, 2025
Geode Capital Management, L.L.C.
245.51K
0.75%
+29.34K
+13.57%
Mar 31, 2025
Currie (Daniel Scott)
109.24K
0.34%
+19.61K
+21.88%
Jun 02, 2025
State Street Global Advisors (US)
56.37K
0.17%
--
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
